Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

2018-07-20 护理研究,2018,32(14):2159-2162.

血液透析饮食

对2017年国际肾营养和代谢学会（ISRNM）《血液透析治疗期间饮食》专家共识中支持透析中营养支持的理由与反对透析中营养支持的理由进行解读，指出透析中营养应被视为血液透析病人标准护理实践的一部分，可提供给血流动力学稳定、无禁忌证且治疗期间无不耐受食物史的病人。

中文标题：

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

发布机构：

发布日期：

2018-07-20

简要介绍：

对2017年国际肾营养和代谢学会（ISRNM）《血液透析治疗期间饮食》专家共识中支持透析中营养支持的理由与反对透析中营养支持的理由进行解读，指出透析中营养应被视为血液透析病人标准护理实践的一部分，可提供给血流动力学稳定、无禁忌证且治疗期间无不耐受食物史的病人。 

作者： 上海中医药大学附属龙华医院 张帆 周文琴 黄柳燕

拓展指南：与血液透析相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017年ISRNM《血液透析治疗期间饮食》专家共识解读)] GetToolGuiderByIdResponse(projectId=1, id=a46381c0016209cd, title=2017年ISRNM《血液透析治疗期间饮食》专家共识解读, enTitle=, guiderFrom=护理研究,2018,32(14):2159-2162., authorId=null, author=, summary=对2017年国际肾营养和代谢学会（ISRNM）《血液透析治疗期间饮食》专家共识中支持透析中营养支持的理由与反对透析中营养支持的理由进行解读，指出透析中营养应被视为血液透析病人标准护理实践的一部分，可提供给血流动力学稳定、无禁忌证且治疗期间无不耐受食物史的病人。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Jul 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>对2017年国际肾营养和代谢学会（ISRNM）《血液透析治疗期间饮食》专家共识中支持透析中营养支持的理由与反对透析中营养支持的理由进行解读，指出透析中营养应被视为血液透析病人标准护理实践的一部分，可提供给血流动力学稳定、无禁忌证且治疗期间无不耐受食物史的病人。 </div> <div><br> </div>作者： 上海中医药大学附属龙华医院 张帆 周文琴 黄柳燕 <div><br> </div> 拓展指南：<strong>与<font color=red>血液透析</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=267131c0015351d9" title="2017 ISRNM共识声明：血液透析治疗期间饮食" target=_blank>2017 ISRNM共识声明：血液透析治疗期间饮食</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=e94e71c001a94396" title="2017 KSN临床实践指南：中东呼吸综合征血液透析治疗" target=_blank>2017 KSN临床实践指南：中东呼吸综合征血液透析治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=9032c1c001a910b0" title="2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）" target=_blank>2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=c78601c00122305b" title="2012 JSDT指南：糖尿病患者血液透析" target=_blank>2012 JSDT指南：糖尿病患者血液透析</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=160b61c001161a96" title="血液透析室建设与管理指南" target=_blank>血液透析室建设与管理指南</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E8%A1%80%E6%B6%B2%E9%80%8F%E6%9E%90" target=_blank>有关血液透析更多指南</a></ul>, tagList=[TagDto(tagId=2080, tagName=血液透析), TagDto(tagId=3229, tagName=饮食)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8752, appHits=475, showAppHits=1, pcHits=5852, showPcHits=3388, likes=120, shares=33, comments=5, approvalStatus=1, publishedTime=Fri Jul 27 22:56:56 CST 2018, publishedTimeString=2018-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jul 27 22:56:56 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:11:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017年ISRNM《血液透析治疗期间饮食》专家共识解读)])
2017年ISRNM《血液透析治疗期间饮食》专家共识解读
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954647, encodeId=8c5b95464e73, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911163, encodeId=4f8291116358, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22c5447875, createdName=ms7000000918637557, createdTime=Sat Dec 26 22:19:08 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804538, encodeId=6c9580453829, content=学习了f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80941556990, createdName=bianxueyan, createdTime=Sat Jul 25 17:42:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334605, encodeId=571033460528, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 28 01:33:05 CST 2018, time=2018-07-28, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954647, encodeId=8c5b95464e73, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911163, encodeId=4f8291116358, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22c5447875, createdName=ms7000000918637557, createdTime=Sat Dec 26 22:19:08 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804538, encodeId=6c9580453829, content=学习了f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80941556990, createdName=bianxueyan, createdTime=Sat Jul 25 17:42:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334605, encodeId=571033460528, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 28 01:33:05 CST 2018, time=2018-07-28, status=1, ipAttribution=)]
    2020-12-26 ms7000000918637557

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954647, encodeId=8c5b95464e73, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911163, encodeId=4f8291116358, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22c5447875, createdName=ms7000000918637557, createdTime=Sat Dec 26 22:19:08 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804538, encodeId=6c9580453829, content=学习了f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80941556990, createdName=bianxueyan, createdTime=Sat Jul 25 17:42:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334605, encodeId=571033460528, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 28 01:33:05 CST 2018, time=2018-07-28, status=1, ipAttribution=)]
    2020-07-25 bianxueyan

    学习了f

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954647, encodeId=8c5b95464e73, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:28 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911163, encodeId=4f8291116358, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22c5447875, createdName=ms7000000918637557, createdTime=Sat Dec 26 22:19:08 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804538, encodeId=6c9580453829, content=学习了f, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80941556990, createdName=bianxueyan, createdTime=Sat Jul 25 17:42:28 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334605, encodeId=571033460528, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 28 01:33:05 CST 2018, time=2018-07-28, status=1, ipAttribution=)]
    2018-07-28 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

相关指南

2017 ISRNM共识声明：血液透析治疗期间饮食

国际肾营养和代谢学会(ISRNM,International Society of Renal Nutrition and Metabolism) · 2017-12-20

2017 KSN临床实践指南：中东呼吸综合征血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2017-06-01

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

暂未更新 · 2017-06-21

2012 JSDT指南：糖尿病患者血液透析

暂未更新 · 2012-03-19

血液透析室建设与管理指南

暂未更新 · 2016-04-20

Baidu
map
Baidu
map
Baidu
map